findmyKOL
Clinical trialNCT01107886CompletedPhase 4Interventional

Does Saxagliptin Reduce the Risk of Cardiovascular Events When Used Alone or Added to Other Diabetes Medications

SponsorAstraZenecaEnrollment18,206Type 2 Diabetes Mellitus
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

536 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Argentina
  • Research Site

    Buenos Aires, Argentina

  • Research Site

    Ciudad Autonom de Buenos Aires, Argentina

  • Research Site

    CiudadAutonoma de Buenos Aires, Argentina

  • Research Site

    Corrientes, Argentina

  • Research Site

    Córdoba, Argentina

  • Research Site

    La Plata, Argentina

  • Research Site

    Lanus Buenos Aires, Argentina

  • Research Site

    Mar del Plata, Argentina

  • Research Site

    Mendoza, Argentina

  • Research Site

    Morón, Argentina

  • Research Site

    Ramos Mejía, Argentina

  • Research Site

    Rosario, Argentina

  • Research Site

    Rosario Santa Fe, Argentina

  • Research Site

    Santa Fe, Argentina

  • Research Site

    Sarandi Buenos Aires, Argentina

  • Research Site

    Villa Ballester, Argentina

Australia
  • Research Site

    Ashford, Australia

  • Research Site

    Fitzroy, Australia

  • Research Site

    Frankston, Australia

  • Research Site

    Garran, Australia

  • Research Site

    Geelong, Australia

  • Research Site

    Launceston, Australia

  • Research Site

    Maroubra, Australia

  • Research Site

    Milton, Australia

  • Research Site

    Sherwood, Australia

  • Research Site

    Southport, Australia

  • Research Site

    Windsor, Australia

Brazil
  • Research Site

    Belém, Brazil

  • Research Site

    Brasília, Brazil

  • Research Site

    Campinas, Brazil

  • Research Site

    Curitiba, Brazil

  • Research Site

    Goiânia, Brazil

  • Research Site

    Marília, Brazil

  • Research Site

    Porto Alegre, Brazil

  • Research Site

    Recife, Brazil

  • Research Site

    Rio de Janeiro, Brazil

  • Research Site

    São Paulo, Brazil

Canada
  • Research Site

    Calgary, Alberta, Canada

  • Research Site

    Red Deer, Alberta, Canada

  • Research Site

    Spruce Grove, Alberta, Canada

496 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 May 2010
Primary completion
31 May 2013
Completion
31 May 2013
Last update posted
17 Jul 2014
Registered enrollment
18,206
Registry id
NCT01107886
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.